Abstract:Background: Catecholamines are commonly used as therapeutic drugs in intensive care medicine to maintain sufficient organ perfusion during shock. However, excessive or sustained adrenergic activation drives detrimental cardiac remodeling and may lead to heart failure. Whether catecholamine treatment in absence of heart failure causes persistent cardiac injury, is uncertain. In this experimental study, we assessed the course of cardiac remodeling and recovery during and after prolonged catecholamine treatment and investigated the molecular mechanisms involved. Results: C57BL/6N wild-type mice were assigned to 14 days catecholamine treatment with isoprenaline and phenylephrine (IsoPE), treatment with IsoPE and subsequent recovery, or healthy control groups. IsoPE improved left ventricular contractility but caused substantial cardiac fibrosis and hypertrophy. However, after discontinuation of catecholamine treatment, these alterations were largely reversible. To uncover the molecular mechanisms involved, we performed RNA sequencing from isolated cardiomyocyte nuclei. IsoPE treatment resulted in a transient upregulation of genes related to extracellular matrix formation and transforming growth factor signaling. While components of adrenergic receptor signaling were downregulated during catecholamine treatment, we observed an upregulation of endothelin-1 and its receptors in cardiomyocytes, indicating crosstalk between both signaling pathways. To follow this finding, we treated mice with endothelin-1. Compared to IsoPE, treatment with endothelin-1 induced minor but longer lasting changes in cardiomyocyte gene expression. DNA methylation-guided analysis of enhancer regions identified immediate early transcription factors such as AP-1 family members Jun and Fos as key drivers of pathological gene expression following catecholamine treatment. Conclusions: The results from this study show that prolonged catecholamine exposure induces adverse cardiac remodeling and gene expression before the onset of left ventricular dysfunction which has implications for clinical practice. The observed changes depend on the type of stimulus and are largely reversible after discontinuation of catecholamine treatment. Crosstalk with endothelin signaling and the downstream transcription factors identified in this study provide new opportunities for more targeted therapeutic approaches that may help to separate desired from undesired effects of catecholamine treatment.

Role of 5-HT2B receptors in cardiomyocyte apoptosis in noradrenaline-induced cardiomyopathy in rats: 5-HT in catecholamine cardiotoxicity

Role Of 5-Ht2b Receptors In Cardiomyocyte Apoptosis In Noradrenaline-Induced Cardiomyopathy In Rats

B-Type Natriuretic Peptide Enhances Mild Hypoxia-Induced Apoptotic Cell Death in Cardiomyocytes

Different Roles Of Alpha(1)-Adrenoceptor Subtypes In Mediating Cardiomyocyte Protein Synthesis In Neonatal Rats

5-HT 3 receptor antagonists protect against pressure overload-induced cardiac hypertrophy in murine

The Role of Α_1-Adrenoceptors in Different States of the Cardiac Myocyte

α 2A -adrenergic blockade attenuates septic cardiomyopathy by increasing cardiac norepinephrine concentration and inhibiting cardiac endothelial activation

Β3-Adrenoceptor Impacts Apoptosis in Cultured Cardiomyocytes Via Activation of PI3K/Akt and P38mapk

Cardiac alpha1-adrenergic receptors and myocardial apoptosis

Abstract P1066: Monoamine Oxidase A And Organic Cation Transporter 3 Coordinate Intracellular Adrenergic Signaling To Calibrate Cardiac Function

Effect in Myocytes From Failing Rat Hearts

Catecholamine treatment induces reversible heart injury and cardiomyocyte gene expression

Elevated MAOA Impairs Intracellular Β 1 ‐adrenegic Signaling and Myocardial Contractility in Heart Failure

Antiapoptotic effect of endothelin-1 in rat cardiomyocytes in vitro

Changes of Humoral Indicators and Cardiomyocyte Apoptosis in Rats with Heart Failure

Protecting The Myocardium: A Role For The Beta 2 Adrenergic Receptor In The Heart

Effects of ACE 2-Ang ( 1-7 )-Mas axis on primary myocardial cell apoptosis : an in vitro study

Monoamine Oxidase A Contributes to Serotonin-But Not Norepinephrine-Dependent Damage of Rat Ventricular Myocytes

Propranolol Alleviates Cardiac Injury After Acute Catecholamine Infusion via p38-MAPK Pathways

Monoamine oxidase A and organic cation transporter 3 coordinate intracellular β1AR signaling to calibrate cardiac contractile function

5-Hydroxytryptamine Enhances L-Type Calcium Current in Norepinephrine-Induced Hypertrophic Ventricular Myocytes